Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study - Wikidata - wikimedia - TriplyDB

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study

http://www.wikidata.org/entity/Q34445856

about

Immunological and Virological Responses to Highly Active Antiretroviral Therapy in HIV-1 Infected Children.Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

P2860

Q40056526-B76D7E03-FF67-43EF-BC90-9FDBB31E4327 Q47432196-28C335C1-3DFD-4821-92D2-0487DD8E81AC

P2860

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study

http://www.wikidata.org/entity/Q34445856

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Safety and effectiveness of co ...... children: a prospective study

@ast

Safety and effectiveness of co ...... children: a prospective study

@en

Safety and effectiveness of co ...... children: a prospective study

@nl

type

label

Safety and effectiveness of co ...... children: a prospective study

@ast

Safety and effectiveness of co ...... children: a prospective study

@en

Safety and effectiveness of co ...... children: a prospective study

@nl

prefLabel

Safety and effectiveness of co ...... children: a prospective study

@ast

Safety and effectiveness of co ...... children: a prospective study

@en

Safety and effectiveness of co ...... children: a prospective study

@nl

P1433

Q34445856-9E25A11D-AA34-4F7F-9882-5CFF9549F6A9

P1476

Q34445856-BC16D916-9347-4C06-8683-04B0FF44E250

P2093

Q34445856-1E5E25B5-B8C2-41C0-98F3-70BB678D718A

Q34445856-4F0BB5D3-2DB1-4957-A018-901DE65BA289

Q34445856-52D41176-03B2-4D24-A7F4-1969E471E41E

Q34445856-8A5E4091-DABC-4FC4-820E-E02893B0298B

Q34445856-8B6A06CA-AB24-4DBE-B850-B82E0A61B3A8

Q34445856-8E95B88A-9AE6-4DE5-AA7F-0F33C178CFDB

Q34445856-8F9604C4-9148-4A6C-A23D-762732C8659E

Q34445856-B6F99479-AE56-4A71-92FB-776FDBF0CC7B

Q34445856-C45832DE-952B-443C-ABDF-FCE45E7A2BAD

Q34445856-F7BAF7AD-1BDF-46AD-A0D2-75B84BEF6D7D

P2860

Q34445856-045FC129-71B7-4564-A201-D406B729FB79

Q34445856-06C14FF9-F4D5-4A47-A706-D245025D654A

Q34445856-07DACD6F-6C01-4B98-8B29-6652F0C900ED

Q34445856-107419A8-7FB4-4696-9AC5-E8F736743CC4

Q34445856-1ABD5CCE-40D8-491E-AF8D-ACB62E05F2E2

Q34445856-216219B3-C093-404E-8759-E398DA36DB55

Q34445856-2696CF62-206C-4172-AF1B-53B7F7197062

Q34445856-2B1937A0-322A-4AF9-AEEA-07CCB935BA84

Q34445856-2D028872-8633-4152-A032-42DEF1E2A161

Q34445856-351AB51F-3F2A-426B-B6CB-7E05A528091E

P304

Q34445856-1B00EF1D-34BA-4990-B026-4B1A7D3422E0

P31

Q34445856-013387FB-FEF2-4E5B-B6EA-23D1AB68D41B

P356

Q34445856-FCF8CDA4-4104-4B43-B888-D6C44840FB94

P407

Q34445856-4F6A1C14-DB33-4817-892A-B8BF6CC5F182

P433

Q34445856-9D388F1D-DED9-4D9C-A7CC-64AA52A3137D

P478

Q34445856-84C68A3F-D5E1-41B8-915E-20A0949A93D8

P50

Q34445856-397048BA-09A5-47B4-AFB7-5C7BA00F5E8B

P577

Q34445856-736C9049-88EF-4DB0-B2CB-F19BB1151226

P5875

Q34445856-6AC06DFE-E494-4EA8-A786-5C249DD4A6FE

P698

Q34445856-78D8227F-52D8-49CA-AB64-782605BE88E4

P921

Q34445856-56662AB9-1A28-4B85-8AF5-9A9DF89EAAF6

Q34445856-EB8C0D71-6AF7-44DC-9F3C-8E96F75DFD28

P932

Q34445856-73A79EAA-A11D-45FF-ABBE-B98ACE6B1345

P356

JOURNAL.PONE.0111948

P1433

P1476

Safety and effectiveness of co ...... children: a prospective study

@en

P2093

Anita Asiimwe

http://www.w3.org/2001/XMLSchema#string

Brenda Asiimwe-Kateera

http://www.w3.org/2001/XMLSchema#string

Diane Tuyishimire

http://www.w3.org/2001/XMLSchema#string

Janneke van de Wijgert

http://www.w3.org/2001/XMLSchema#string

Joep M A Lange

http://www.w3.org/2001/XMLSchema#string

Kimberly R Boer

http://www.w3.org/2001/XMLSchema#string

Narcisse Muganga

http://www.w3.org/2001/XMLSchema#string

Peter Reiss

http://www.w3.org/2001/XMLSchema#string

Philippe R Mutwa

http://www.w3.org/2001/XMLSchema#string

Sibyl P M Geelen

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study

Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS.

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer

Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.

Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study

Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition.

Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.

Risk factors for pre-treatment mortality among HIV-infected children in rural Zambia: a cohort study

Six-month gain in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children.

Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.

P304

e111948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0111948

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267755347

http://www.w3.org/2001/XMLSchema#string

P698

25365302

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4218827

http://www.w3.org/2001/XMLSchema#string